Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue: 2011-2012

Historic Current Deferred Revenue for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $2.9 million.

  • Sonoma Pharmaceuticals' Current Deferred Revenue rose 54.81% to $2.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was $2.9 million, marking a year-over-year increase of 54.81%. This contributed to the annual value of $1.6 million for FY2012, which is 10.45% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Current Deferred Revenue stood at $2.9 million for Q4 2012, which was down 0.24% from $2.9 million recorded in Q3 2012.
  • Over the past 5 years, Sonoma Pharmaceuticals' Current Deferred Revenue peaked at $2.9 million during Q3 2012, and registered a low of $1.6 million during Q1 2012.
  • For the 2-year period, Sonoma Pharmaceuticals' Current Deferred Revenue averaged around $2.1 million, with its median value being $1.9 million (2011).
  • The largest annual percentage gain for Sonoma Pharmaceuticals' Current Deferred Revenue in the last 5 years was 54.81% (2012), contrasted with its biggest fall of 13.26% (2012).
  • Over the past 2 years, Sonoma Pharmaceuticals' Current Deferred Revenue (Quarterly) stood at $1.9 million in 2011, then soared by 54.81% to $2.9 million in 2012.
  • Its last three reported values are $2.9 million in Q4 2012, $2.9 million for Q3 2012, and $1.6 million during Q2 2012.